ARTL
Artelo Biosciences, Inc. Common Stock
stockNASDAQ
artelo biosciences is a biopharmaceutical company dedicated to applying true biopharma discipline in leveraging past research and leading-edge, world-class science to accelerate the development and commercialization of a diverse portfolio of novel, endocannabinoid system modulating therapeutics. our programs have the potential to dramatically improve patient care in major markets. with our headquarters team in san diego, california, usa and our european office in dublin, ireland, artelo established a presence in key global biopharma innovation hubs with close access to world-class research expertise. artelo's research and development leverages the skill, knowledge and experience of our collaboration partners in europe and north america.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.11 | 2026-10-12 | -12.86% | -1.749 |
| 1M | 3.94 | 2026-09-18 | -31.22% | -6.322 |
| 3M | 10.35 | 2026-07-17 | -73.82% | 0.122 |
| 6M | 39.96 | 2026-04-17 | -93.22% | 1.149 |
| 1Y | 113.13 | 2025-10-17 | -97.61% | -1.874 |
| 2Y | 186.30 | 2024-10-18 | -98.55% | — |
| 5Y | 1,870.61 | 2021-10-18 | -99.86% | 0.619 |
Artelo Biosciences, Inc. Common Stock (NASDAQ:ARTL) stock price today is $2.71, and today's volume is 12,357. ARTL is down 1.095% today. The 30 day average volume is 947,641. ARTL market cap is $1.48M with 547,774 shares outstanding.